MYOC and glaucoma: Currently, in the absence of clinical details, a multigenerational familial inheritance pattern and supporting laboratory data, the pathogenicity of any given mutation is not definitive (Scelsi et al., 2021) because recent genome-wide association studies demonstrate that mutations in MYOC in general are not associated with glaucoma (Craig et al., 2020).